Steven H. Bernstein

6.8k total citations · 2 hit papers
109 papers, 5.1k citations indexed

About

Steven H. Bernstein is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Steven H. Bernstein has authored 109 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 40 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Steven H. Bernstein's work include Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Immune Cell Function and Interaction (15 papers). Steven H. Bernstein is often cited by papers focused on Lymphoma Diagnosis and Treatment (43 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Immune Cell Function and Interaction (15 papers). Steven H. Bernstein collaborates with scholars based in United States, United Kingdom and Canada. Steven H. Bernstein's co-authors include Richard I. Fisher, Richard P. Phipps, Jonathan W. Friedberg, Shannon P. Hilchey, John P. Leonard, Mayuka Horikawa, David J. DiLillo, Koichi Yanaba, E. William St. Clair and Paul Szabolcs and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Steven H. Bernstein

105 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

2010 877 citations Steven H. Bernstein et al. profile →
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

2006 553 citations Richard I. Fisher, Steven H. Bernstein et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven H. Bernstein United States	34	1.9k	1.9k	1.7k	1.4k	1.1k	109	5.1k
Antonio Pinto Italy	40	2.2k 1.2×	2.3k 1.2×	1.6k 0.9×	1.3k 0.9×	1.1k 1.0×	239	5.6k
Eric Tse China	36	2.2k 1.1×	1.9k 1.0×	1.5k 0.9×	1.3k 0.9×	410 0.4×	111	4.7k
Kiyohiko Hatake Japan	41	2.3k 1.2×	1.1k 0.6×	1.2k 0.7×	1.3k 0.9×	741 0.7×	237	5.1k
Thierry Fest France	41	1.8k 1.0×	1.6k 0.8×	2.1k 1.3×	1.4k 1.0×	862 0.8×	145	5.0k
Rebecca Elstrom United States	31	1.9k 1.0×	1.8k 1.0×	1.3k 0.8×	1.8k 1.3×	813 0.7×	83	5.4k
Günter Fingerle‐Rowson Germany	39	1.7k 0.9×	2.0k 1.1×	3.9k 2.3×	801 0.6×	1.5k 1.3×	91	6.5k
George Z. Rassidakis United States	43	2.4k 1.3×	1.9k 1.0×	1.1k 0.7×	2.4k 1.7×	678 0.6×	140	5.2k
Wei Xu China	34	1.4k 0.7×	1.6k 0.9×	979 0.6×	1.8k 1.2×	1.4k 1.2×	367	4.5k
Nalini Janakiraman United States	19	1.1k 0.6×	1.5k 0.8×	867 0.5×	1.1k 0.8×	1.4k 1.2×	72	4.3k
David Spaner Canada	35	1.9k 1.0×	954 0.5×	1.8k 1.1×	1.4k 1.0×	1.4k 1.2×	123	4.7k

Countries citing papers authored by Steven H. Bernstein

Since Specialization

Citations

This map shows the geographic impact of Steven H. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Bernstein more than expected).

Fields of papers citing papers by Steven H. Bernstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Bernstein. The network helps show where Steven H. Bernstein may publish in the future.

Co-authorship network of co-authors of Steven H. Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Bernstein. A scholar is included among the top collaborators of Steven H. Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Bernstein. Steven H. Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Alexander F., Shannon P. Hilchey, Ollivier Hyrien, et al.. (2016). Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node. PLoS ONE. 11(5). e0155347–e0155347. 20 indexed citations

Friedberg, Jonathan W., Daruka Mahadevan, Daniel O. Persky, et al.. (2013). Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas. Journal of Clinical Oncology. 32(1). 44–50. 161 indexed citations

Bernstein, Steven H. & Richard Burack. (2009). The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology. 2009(1). 532–541. 29 indexed citations

Sniderhan, Lynn F., et al.. (2009). Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma. Experimental Hematology. 37(11). 1295–1309. 18 indexed citations

Biswas, Tithi, Sughosh Dhakal, Rui Chen, et al.. (2009). Involved Field Radiation After Autologous Stem Cell Transplant for Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology*Biology*Physics. 77(1). 79–85. 27 indexed citations

García-Bates, Tatiana M., Geniece M. Lehmann, Patricia J. Simpson‐Haidaris, et al.. (2008). Role of Peroxisome Proliferator‐Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies. PPAR Research. 2008(1). 834612–834612. 29 indexed citations

Mendler, Jason H., Jennifer L. Kelly, Susan Voci, et al.. (2008). Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma. Annals of Oncology. 19(10). 1759–1764. 28 indexed citations

Hilchey, Shannon P. & Steven H. Bernstein. (2007). Use of CFSE to MonitorEx VivoRegulatory T-cell Suppression of CD4⁺and CD8⁺T-cell Proliferation within Unseparated Mononuclear Cells from Malignant and Non-Malignant Human Lymph Node Biopsies. Immunological Investigations. 36(5-6). 629–648. 19 indexed citations

Ryan, Elizabeth P., Stephen J. Pollock, Kuljeet Kaur, et al.. (2006). Constitutive and activation-inducible cyclooxygenase-2 expression enhances survival of chronic lymphocytic leukemia B cells. Clinical Immunology. 120(1). 76–90. 24 indexed citations

10.

Ryan, Elizabeth P., et al.. (2005). Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Antibody Production. The Journal of Immunology. 174(5). 2619–2626. 82 indexed citations

11.

Ryan, Elizabeth P., et al.. (2005). Activated Human B Lymphocytes Express Cyclooxygenase-2 and Cyclooxygenase Inhibitors Attenuate Ab Production. The Journal of Immunology. 174(8). 5134–5134. 1 indexed citations

12.

Ray, Denise M., Filiz Akbıyık, Steven H. Bernstein, & Richard P. Phipps. (2005). CD40 Engagement Prevents Peroxisome Proliferator-Activated Receptor γ Agonist-Induced Apoptosis of B Lymphocytes and B Lymphoma Cells by an NF-κB-Dependent Mechanism. The Journal of Immunology. 174(7). 4060–4069. 53 indexed citations

13.

Ray, Denise M., Steven H. Bernstein, & Richard P. Phipps. (2004). Human multiple myeloma cells express peroxisome proliferator-activated receptor γ and undergo apoptosis upon exposure to PPARγ ligands. Clinical Immunology. 113(2). 203–213. 46 indexed citations

14.

Hess, Stephen D., Nejat K. Egilmez, Timothy Anderson, et al.. (2003). Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ. The Journal of Immunology. 170(1). 400–412. 57 indexed citations

15.

Orner, James B., et al.. (2000). Primary non-Hodgkin's lymphoma of bone: Treatment and outcome. Radiology and Oncology. 34(1). 27–33.

16.

Wetzler, Meir, Maria R. Baer, Steven H. Bernstein, et al.. (1997). Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.. Journal of Clinical Oncology. 15(6). 2262–2268. 38 indexed citations

17.

Stone, Richard M., Steven H. Bernstein, George D. Demetri, et al.. (1994). Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia Research. 18(10). 769–776. 13 indexed citations

18.

Bernstein, Steven H., Surender Kharbanda, Matthew L. Sherman, Richard M. Stone, & D Kufe. (1991). Inhibition of protein kinase C is associated with a decrease in c‐myc expression in human myeloid leukemia cells. FEBS Letters. 294(1-2). 73–76. 15 indexed citations

19.

Kharbanda, Surender, Takashi Nakamura, Richard M. Stone, et al.. (1991). Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation.. Journal of Clinical Investigation. 88(2). 571–577. 92 indexed citations

20.

Bernstein, Steven H., Matthew L. Sherman, Ralf Hass, et al.. (1991). Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells. Biochemical Pharmacology. 42(2). 403–407. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact